UK MHRA to launch consultation on access scheme to unlicensed drugs
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency is expected to launch shortly a public consultation on implementing its much-awaited scheme for allowing patients to have access to promising new medicines before they are licensed for marketing.